ANTI-TGF-BETA ANTIBODIES ISOLATED AND PHARMACEUTICALS CONTAINING THESE ANTIBODIES

VN10060513BActive Publication Date: 2026-09-03GENENTECH INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202206185
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2021-03-18
Publication Date: 2026-09-03
Estimated Expiration: 2041-03-18

Application Information

Patent Timeline

18 Mar 2021

Application

VN1202206185

03 Sep 2026

Publication

VN10060513B

Inventors: LIANG, Wei-Ching; ARRON, Joseph R.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention proposes a selective anti-TGFp antibody, a method for generating this antibody, and a pharmaceutical containing it. Specifically, the invention proposes a diclonal antibody against TGF2, TGF[33, and TGFp2 / 3, for example, for the treatment of fibrosis and other TGF0-related disorders.

Need to check novelty before this filing date? Find Prior Art

Explore free tools for quick IP tasks

Patent Information

Abstract